KO Cancer Act
USA118th CongressHR-6807| House
| Updated: 12/15/2023
Brian K. Fitzpatrick
Republican Representative
Pennsylvania
Cosponsors (3)
Health Subcommittee, Appropriations Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the Committee on Appropriations, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
AppropriationsCancerCongressional oversightDrug therapyGovernment studies and investigationsMedical researchPrescription drugsResearch administration and funding
KO Cancer Act
USA118th CongressHR-6807| House
| Updated: 12/15/2023
Timeline
Introduced in House
Referred to the Committee on Appropriations, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Brian K. Fitzpatrick
Republican Representative
Pennsylvania